The greenlight for Journavx (suzetrigine), which comes on the heels of a $7.4 billion opioid settlement, could spark momentum ...

It's the first new pharmaceutical approach to treating pain in over 20 years, designed to eliminate risks of addiction and overdose associated with opioids.

Multiple states have reached a tentative new agreement with the Sackler family, who made billions of dollars marketing OxyContin, the drug that set off the U.S. opioid crisis. New York State Attorney ...

Last week’s settlement that would see Purdue Pharma and its owners, the Sackler family, pay $7.4 billion to resolve lawsuits filed by state and local governments across the country is ...

Opioid abuse tells a tragic American story since avoidable deaths began in the 1990s. Nearly 700,000 people lost their lives to overdoses of OxyContin and offshoots of the highly addictive ...

Following efforts made by Florida’s Attorney’s General Office, as well as other states, a $7.4 billion multistate settlement ...

Last week, members of the Sackler family, which owns the pharmaceutical company known for selling OxyContin, agreed to a $7.4 ...

Pennsylvania stands to receive up to $212 million paid out by the family and firm behind the nationwide saturation of ...

Members of the Sackler family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion to settle lawsuits over the toll of the ...

Megan Giles Cooney is a writer and artist, who is a summer resident of Northport. Reach her at [email protected].

The wheels of justice can grind slowly, especially when large amounts of money are involved, but justice of some sort is ...

Purdue Pharma and its owners, the Sackler family, have reached a $7.4bn settlement with US states to resolve a long-running ...